MedPath

Evaluation of positive psychology’s effect on depression, anxiety, stress and glycemic control in diabetic type 2 patients

Not Applicable
Recruiting
Conditions
Type 2 diabetes mellitus.
Type 2 diabetes mellitus
Registration Number
IRCT20130311012782N27
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Type 2 diabetes with the approval of a specialist
The history of regular visits to the center for at least the past 6 months
Age between 30 and 59 years
HbA1C between 9-7%
Absence of alcohol and substance abuse
Have at least high school education level
Ability to attend medical sessions
Lack of pregnancy and lactation
The history of diabetes for at least 6 months
Earn a minimum score of 7 from the DASS 21 questionnaire before starting the study
Failure to receive psychological treatment in the past year

Exclusion Criteria

Absence in more than 3 sessions in the treatment process
Unwillingness to continue treatment
The occurrence of major stresses and unexpected accidents in each stage of the study
Acute psychological illness in each stage of the study
Having chronic illnesses, such as cancer or any other serious medical condition, except diseases associated with complications of diabetes or diseases associated with diabetes
Need to start insulin treatment during the design
Participate in psychotherapy sessions outside the research project protocol.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fasting Blood Sugar. Timepoint: beginning of study and 8 weeks after intervention. Method of measurement: Using the Pars Test Kit, Made by Iran.;HbA1C. Timepoint: beginning of study and 8 weeks after intervention. Method of measurement: Using the Pars Test Kit, Made by Iran.;Anxiety, depression and stress. Timepoint: beginning of study and 8 weeks after intervention. Method of measurement: DASS 21 anxiety, depression and stress questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath